Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 3. (A) Screening of the inhibitors against MERS-CoV infection. The plaque formation assay was performed with 15 compounds. Prior to MERS-CoV infection, MERS-CoV was incubated with each compound (10 μM) for 30 min at 37°C and then added to Vero cells to infect with MERS-CoV. After 4 days of incubation in DMEM/F12 containing 0.6% oxoid agar, the plaques were observed by staining with crystal violet and then counted.
Biomolecules & Therapeutics 2024;32:262~265 https://doi.org/10.4062/biomolther.2024.001
© Biomolecules & Therapeutics